Inventor · disambiguated record
Tsukasa Suzuki
Also filed as: SUZUKI TSUKASA
8 granted patents·11 pending applications·270 citations·filing 2003–2025
87Inventor score
Top patents by PatentIndex Score
19 records- 0196US9334331B2Bispecific antibodiesIGAWA TOMOYUKI·Filed 2011·Granted May 10, 2016·221 cites·33 claims
- 0295US10450381B2Methods of treatment that include the administration of bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·28 cites·84 claims
- 0392US2025382387A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0489US2024376228A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0588US2024059795A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0684US2023212315A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0783US11214623B2Antibody capable of neutralizing substance having activity alternative to function of coagulation factor VIII (FVIII)CHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jan 4, 2022·3 cites·10 claims
- 0881US2022267470A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0977US2025154285A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1074US8252287B2Blood coagulation factor VIII activation-enhancing antibodiesTAKEYAMA MASAHIRO·Filed 2009·Granted Aug 28, 2012·6 cites·11 claims
- 1174US7517965B2Non-neutralizing anti-aPC antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Apr 14, 2009·6 cites·15 claims
- 1270US9550835B2Anti-DDR1 antibody having anti-tumor activityONO MEI·Filed 2012·Granted Jan 24, 2017·3 cites·11 claims
- 1370US2019315884A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1469US9175091B2Monoclonal antibody capable of binding to anexelekto, and use thereofKITAZAWA TAKEHISA·Filed 2008·Granted Nov 3, 2015·3 cites·7 claims
- 1564US2014370018A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1664US2014037632A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1763US2017022293A1Nucleic acid encoding bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1854US10451627B2Method for assaying soluble GPC3 proteinCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Oct 22, 2019·0 cites·6 claims
- 1937US2016053019A1Monoclonal antibody capable of binding to anexelekto, and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tsukasa Suzuki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →